CJC-1295 with DAC (CD5) is a long-acting GHRH analog research peptide used for research on growth hormone release pathways, receptor signaling, and endocrine mechanisms.
CJC-1295 with DAC (CD5) is a GHRH analog research peptide modified with DAC (Drug Affinity Complex), derived from amino acid fragments 1-29 of GHRH. This peptide contains 29 amino acids, and its stability and research application value have been enhanced through structural modifications. CJC-1295 with DAC is primarily used to explore the growth hormone-releasing hormone receptor-related signaling pathway, peptide hormone regulatory mechanisms, and GH/IGF-related biological processes. The product is typically supplied as a white to off-white lyophilized powder, and its quality is assessed by HPLC purity analysis and LC-MS identification.
CJC-1295 with DAC is primarily used in basic medical and molecular biology research, including studies on GHRH receptor activation mechanisms, growth hormone release regulation, pituitary cell signal transduction, endocrine system regulation mechanisms, and the structure-function relationship of peptide drugs. Researchers utilize this research peptide as an experimental tool to analyze GH/IGF-1 axis-related biological processes and their regulatory mechanisms.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Acetate BPC-157 (BC10) is a synthetic polypeptide research compound composed of ...
BPC-157 5mg + TB-500 5mg (BB10) is a compound lyophilized product composed of tw...
BPC-157 10mg + TB-500 10mg (BB20) is a compound research peptide product compose...
Contact our team for volume discounts and custom peptide services